ADVERTISEMENT
Evaluating Real-World Utilization of ctDNA Testing in the Management of Patients With Colorectal Cancer
Kristin Savill, PhD, Cardinal Health, Dublin, OH, discusses her survey-based study that evaluated the utilization of circulating tumor DNA (ctDNA) testing in the management of colorectal cancer (CRC) among practicing community oncologists in the US.
Findings from this study demonstrate a limited adoption of ctDNA testing by community oncologists in the care of patients with CRC due to insufficient demonstration of clinical utility, limited familiarity with methodology, and reimbursement issues.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Current Issue
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Subscribe
Advertisement
Advertisement
Advertisement
Recent Stories
Advertisement